Drug Shortage Report for AURO-DAPAGLIFLOZIN / METFORMIN

Last updated on 2025-01-29 History
Report ID 242954
Drug Identification Number 02533073
Brand name AURO-DAPAGLIFLOZIN / METFORMIN
Common or Proper name Auro-Dapagliflozin-Metformin`
Company Name AURO PHARMA INC
Market Status MARKETED
Active Ingredient(s) METFORMIN HYDROCHLORIDE DAPAGLIFLOZIN
Strength(s) 850MG 5MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging sizes (GTIN)

Click here to see a list of all reports for this drug.

(See additional packaging sizes)
Additional packaging sizes 60
ATC code A10BD
ATC description BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS
Reason for shortage Demand increase for the drug.
Anticipated start date
Actual start date 2024-11-14
Estimated end date 2025-01-28
Actual end date 2025-01-28
Shortage status Resolved
Updated date 2025-01-29
Company comments Alternative pack size of 100's and 500's available for sale.
Health Canada comments
Tier 3 Status No
Contact Address 3700 STEELES AVENUE WEST, SUITE 402
WOODBRIDGE, ONTARIO
CANADA L4L 8K8
Company contact information Anahita Rostami

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v8 2025-01-29 English Compare
v7 2025-01-28 French Compare
v6 2025-01-28 English Compare
v5 2024-11-15 French Compare
v4 2024-11-15 English Compare
v3 2024-11-15 English Compare
v2 2024-11-14 French Compare
v1 2024-11-14 English Compare

Showing 1 to 8 of 8